Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04908709 · ClinicalTrials.gov registry record · NA
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
A NA study of Malignant Brain Glioma, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 3
- Study locations
NCT04908709: Recruiting NA study of Malignant Brain Glioma, sponsored by Emory University.
NCT04908709 is a NA study of Malignant Brain Glioma that is actively recruiting participants, run by Emory University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04908709, a NA study of Malignant Brain Glioma, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 3
- Study locations
Study Summary
This trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, such as spectroscopic MRI may help to map the differences in tumor metabolism compared to healthy tissue without injection of any contrast agent.
Primary Outcome
The spatial relationship between baseline sMRI abnormalities and tumor recurrence will be reported and proportion of overlap will be quantified.
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- DEVICE Proton Therapy
Study Locations (3)
Georgia
- Emory Proton Therapy Center - Atlanta
- Children's Healthcare of Atlanta - Scottish Rite - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2030-10-13 |
| Phase | NA |
What NCT04908709 shows while recruiting
NCT04908709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Malignant Brain Glioma appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Spectroscopic Imaging is the first listed.
NCT04908709 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04908709 about?
NCT04908709 is a clinical study titled "Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors". This trial studies how well spectroscopic magnetic resonance imaging (MRI) guided proton therapy works in assessing metabolic change in pediatric patients with brain tumors. The non-invasive imaging, such as spectroscopic MRI may help to map the differences in tumor metabolism compared to healthy ti...
What is the current status of trial NCT04908709?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2018-12-20. Estimated completion is 2030-10-13.
What conditions does trial NCT04908709 study?
This clinical trial studies the following conditions: Malignant Brain Glioma.
What interventions are being tested in trial NCT04908709?
The interventions under investigation include: Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Proton Therapy (DEVICE).
Who is sponsoring clinical trial NCT04908709?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04908709 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Brain Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04908709's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI